The soundbite recording captures Dr. Ramien's discussion of disease modification concepts in atopic dermatitis, exploring current understanding and approaches to altering disease progression.

The soundbite recording captures Dr. Paller's discussion examining whether early therapeutic intervention can influence the natural course of atopic dermatitis. The presentation explores the potential for timely treatment approaches to modify disease trajectory.

This educational video focuses on the role of type 2 inflammation in atopic dermatitis (AD) and prurigo nodularis (PN), examining how this inflammatory process contributes to cutaneous manifestations in both conditions.

Dr. Elmariah discusses atopic dermatitis and prurigo nodularis as distinct diseases that can coexist in some patients. The presentation addresses the diagnostic considerations and explores the multidimensional burden of both conditions on patients' quality of life.

Podcast Dr. Dana Hajan

This video highlights the key insights from the 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report, presenting a clear, structured, and evidence-based approach to the diagnosis, assessment, and management of COPD.

This video highlights that the burden of atopic dermatitis in adults extends beyond skin symptoms, encompassing a broad spectrum of atopic and non-atopic comorbidities. These related conditions have a major impact on patient care, clinical decisions, and overall quality of life.

This video explores the long-term, multi-dimensional burden of moderate-to-severe atopic dermatitis, highlighting its impact beyond the skin. It emphasizes the importance of early intervention targeting type 2 inflammation to alter the disease course and prevent long-term comorbidities.

Discover the science beyond histamine: This video reveals how chronic itch in atopic dermatitis is predominantly mediated through non-histaminergic pathways. Learn how IL-4 and IL-13, key drivers of type 2 inflammation, create a critical intersection between inflammatory cascades and neural itch signaling. Understand the clinical implications of targeting these dual cytokines to simultaneously address both inflammation and the persistent itch cycle that significantly impacts patient quality of life.